Limes Schlosskliniken AG: A Strategic Investment Opportunity

NuWays AG has initiated coverage on Limes Schlosskliniken AG, recommending a "BUY" with a target price of EUR 600 over the next 12 months. Limes Schlosskliniken, a leading provider of psychiatric and psychosomatic care, operates clinics across Germany, Switzerland, and Liechtenstein. The company capitalizes on the rising demand for mental health services in the DACH region, driven by public-sector limitations and increasing prevalence of mental health disorders.

With its interdisciplinary approach and emphasis on clinical governance, Limes has created a robust therapeutic model. The opening of new clinics in 2025 expands its reach, particularly in addressing youth mental health needs. As new facilities ramp up, the company expects over 20% annual sales growth through FY28, along with significant margin improvements.

This strategic position reflects a compelling growth narrative in premium mental healthcare, making Limes a strong investment prospect.